The concept of using the contractile power of skeletal muscle to assist the heart was first proposed in 1959,' but further work was initially discouraged by the finding that skeletal muscle fatigued rapidly if subjected to the continuous work necessary for cardiac assistance. An important development was the demonstration that cross-innervation of a fast-twitch muscle with the motor nerve of a slowcontracting muscle altered its functional characteristics to resemble the slow type muscle, which is more fatigueresistent.2 Later, Salmons and Vrbova discovered that the same phenomenon could be achieved by subjecting a fast muscle to chronic, low frequency electrical stimulation.3 The possibility that this phenomenon might be exploited to adapt skeletal muscle for cardiac-type work was first suggested in 1981 7 and resulted in a considerable revival of interest in the subject. But after division of collateral blood vessels to the latissimus dorsi during its mobilisation from the chest wall, the distal half of the muscle becomes ischaemic. A three week vascular delay period, before chronic stimulation of the muscle, allows recovery of normal resting and exerciseinduced blood flow.'9 21 22 It has also been emphasised that, to generate cardiac-type work from skeletal muscle, a burst-pattern of stimulation of the motor nerve is necessary to induce mechanical summation of contractile force. 23 Sophisticated, programmable pacemakers are now available that can sense the electrocardiogram and deliver an appropriately timed burst stimulus to the motor nerve of the muscle. 24 Cardiomyoplasty attempts to use skeletal muscle work to support cardiac function have become polarised into two main approaches. One is in the form of a cardiomyoplasty, in which the muscle is wrapped around the heart, such that it may directly augment myocardial contraction. The alternative method provides indirect assistance, often with aortic counterpulsation techniques. In the cardiomyoplasty procedure, the latissimus dorsi muscle is stimulated to contract synchronously with systole. This operation was first performed experimentally in 1959 with diaphragm muscle,' and later, in 1968, using latissimus dorsi. 25 be related to the configuration of the muscle wrap, which encompasses a large radius of curvature, and thus (according to Laplace's Law) acts at a mechanical disadvantage when the aim is to develop a significant pressure change within the left ventricle." In addition, electrical conditioning of skeletal muscle to a fatigue-resistant form reduces both the power output and shortening velocity; this will further prejudice the maximum tension developed by the muscle during the systolic interval." It may be that symptomatic improvement after cardiomyoplasty derives in part from a more passive role of the muscle flap, which prevents further dilatation of the heart and perhaps reduces myocardial wall stress by virtue of an effective increase in wall thickness."'4
Though the precise role of cardiomyoplasty is currently uncertain, an important report has recently appeared from Sao Paulo, Brazil.'5 Of 29 patients with dilated cardiomyopathy, 13 underwent cardiomyoplasty and 16, who refused the procedure, continued to receive medical treatment. Although this was not a randomised trial, the two study groups were comparable in other respects. In 10 of the 13 patients functional state (New York Heart Association classification) improved after cardiomyoplasty, and mean left ventricular ejection fraction increased by about 30%. However, of particular interest was the finding of improved 18-month actuarial survival in the cardiomyoplasty group compared with those treated medically (80% v 31%). This is the first study to suggest such a survival advantage. Auxiliary studies.4" This method has the advantage that thromboembolic complications are avoided because foreign surfaces do not come into direct contact with blood. One disadvantage is that the degree of assist is limited by the volume of blood that can be displaced using this configuration. One answer is to enlarge the diameter of the aorta with a patch, so as to augment volume displacement."
An alternative method for generating counterpulsation has been to exploit the concept of the intra-aortic balloon pump, already a widely accepted form of clinical cardiac assist. A counterpulsation system powered by skeletal muscle has been devised. It consists ofa cylindrical housing containing a silicone bladder that is anastomosed to the aorta. The inner bladder is displaced pneumatically by compression of a bulb placed either within an SMV44 or beneath the intact latissimus dorsi muscle.45 During muscle stimulation aortic diastolic pressure augmentation has been effective for up to several weeks. A major disadvantage of this device is that the vehicle used for transmitting pressure changes between the two chambers, whether gas or liquid, tends to leak from the system, thereby impairing the efficiency.
While conditioned skeletal muscle currently offers a realistic means of providing functional support for the failing myocardium, more research is required to define the optimal mode of assist for different patient subgroups. The mechanism by which cardiomyoplasty augments cardiac function is unclear, though an improvement in symptoms after the procedure is being increasingly reported, particularly in patients with dilated cardiomyopathy. SMVs, on the other hand, have the potential to replace left or right ventricular function, and have pumped effectively in the canine circulation for more than a year. With continued improvements in SMV design the future for this mode of support is promising. 
